D
Decheng
Decheng is a Series A to Series C stage investment firm. It has made 3 investments. Their most common stage is series-a (40% of deals). Average disclosed round size is $45.0M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
MC
Min Cui
Founder and Managing Director
MC
Min Cui
Founder and Managing Director
PC
Peter Colabuono
Managing Director
VT
Victor Tong
Managing Director
VT
Victor Tong
Managing Director
DZ
Dan Zabrowski
Venture Partner
QX
Qiang Xu
Partner at Decheng Capital
AL
Aaron Li
Principal
W(
Weizhi (Aaron) Li
Healthcare Investment
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| KKind Pharmaceuticals | Series C | — | Jan 2025 |
| KKind Pharmaceuticals | Series B | $50M | Jan 2021 |
| KKind Pharmaceuticals | Series A | $35M | Jan 2019 |
| AAccuragen | Series A | — | Jan 2015 |
| SSinomed | Ipo | $50M | — |
Top Co-Investors
Decheng Capital3 shared
Northern Light Venture Capital2 shared
Gaorong Capital2 shared
WS Investment Company1 shared
Stanford's StartX Fund1 shared
Last updated: 14 September 2026